MedPath

The Application of a Biphasic Calcium Sulfate Graft Material in Sinus Floor Elevation

Not Applicable
Recruiting
Conditions
Edentulism Nos
Alveolar Bone Loss
Interventions
Procedure: Sinus floor elevation (SFE)
Diagnostic Test: preoperative cone beam computed tomography (CBCT)
Diagnostic Test: postoperative CBCT
Diagnostic Test: bone core biopsy
Procedure: dental implant placement
Procedure: fixed dental prosthesis (FDP) fabrication
Device: bone grafting
Registration Number
NCT06533397
Lead Sponsor
Semmelweis University
Brief Summary

Pneumatization of the maxillary sinus may lead to insufficient bone volume for dental implant placement in the edentulous posterior maxilla. Sinus floor elevation (SFE) surgery with the lateral window technique is a safe and predictable surgical intervention to restore bone height in the maxillary premolar and molar areas. According to the literature, several bone graft materials may be successfully applied for SFE surgery. There is a lack of evidence regarding the application of biphasic calcium sulfate (BCS) for SFE. The healing period following staged SFE is 2-9 months.

The aim of this study is:

* to evaluate the success of SFE surgery using BCS as graft material,

* to compare the microarchitecture of the augmented bone depending on the healing period,

* to evaluate the success of dental implants placed in the augmented bone and that of the prostheses delivered on the dental implants.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients over the age of 18 years,
  • Patients who need dental implant-borne prostheses,
  • Patients with insufficient bone height in the posterior maxilla due to sinus pneumatization.

Exclusion criteria:

.• Patients who had major systemic diseases as classified by the American Society of Anesthesiologists (ASA grades III-IV),

  • psychiatric contraindications,
  • patients on medication interfering with bone metabolism, including steroid therapy and antiresorptive medication,
  • radiation to the head or neck region within the previous five years,
  • localized periapical disease, odontogenic and nonodontogenic cysts, and maxillary sinusitis,
  • evidence of uncontrolled periodontal disease,
  • Alcohol Use Disorder defined by the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5),
  • recreational drug abuse,
  • heavy smoking (>10 cigarettes/day),
  • diseases of the oral mucosa, including blisters and ulcers, i.e.: red and white lesions, pigmented lesions, benign tumors of the oral cavity, and oral cancer. Leukoplakia, Erythroplakia, Precancerous lesions, Oral squamous cell carcinoma and malign tumors of the soft and hard tissues, Oral candidiasis, Oral lichen planus, Psoriasis, Pemphigus, and Pemphigoid.
  • pregnancy or nursing,
  • poor oral hygiene
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
6-month healing periodbone graftingStaged SFE is performed; following a 6-month-long healing period, bone core biopsy samples are harvested from the augmented bone, and dental implants are placed.
3-month healing periodfixed dental prosthesis (FDP) fabricationStaged SFE is performed; following a 3-month-long healing period, bone core biopsy samples are harvested from the augmented bone, and dental implants are placed.
6-month healing periodSinus floor elevation (SFE)Staged SFE is performed; following a 6-month-long healing period, bone core biopsy samples are harvested from the augmented bone, and dental implants are placed.
6-month healing periodfixed dental prosthesis (FDP) fabricationStaged SFE is performed; following a 6-month-long healing period, bone core biopsy samples are harvested from the augmented bone, and dental implants are placed.
6-month healing periodpreoperative cone beam computed tomography (CBCT)Staged SFE is performed; following a 6-month-long healing period, bone core biopsy samples are harvested from the augmented bone, and dental implants are placed.
6-month healing periodpostoperative CBCTStaged SFE is performed; following a 6-month-long healing period, bone core biopsy samples are harvested from the augmented bone, and dental implants are placed.
3-month healing periodbone graftingStaged SFE is performed; following a 3-month-long healing period, bone core biopsy samples are harvested from the augmented bone, and dental implants are placed.
6-month healing periodbone core biopsyStaged SFE is performed; following a 6-month-long healing period, bone core biopsy samples are harvested from the augmented bone, and dental implants are placed.
3-month healing periodSinus floor elevation (SFE)Staged SFE is performed; following a 3-month-long healing period, bone core biopsy samples are harvested from the augmented bone, and dental implants are placed.
3-month healing periodpreoperative cone beam computed tomography (CBCT)Staged SFE is performed; following a 3-month-long healing period, bone core biopsy samples are harvested from the augmented bone, and dental implants are placed.
3-month healing periodpostoperative CBCTStaged SFE is performed; following a 3-month-long healing period, bone core biopsy samples are harvested from the augmented bone, and dental implants are placed.
3-month healing periodbone core biopsyStaged SFE is performed; following a 3-month-long healing period, bone core biopsy samples are harvested from the augmented bone, and dental implants are placed.
3-month healing perioddental implant placementStaged SFE is performed; following a 3-month-long healing period, bone core biopsy samples are harvested from the augmented bone, and dental implants are placed.
6-month healing perioddental implant placementStaged SFE is performed; following a 6-month-long healing period, bone core biopsy samples are harvested from the augmented bone, and dental implants are placed.
Primary Outcome Measures
NameTimeMethod
Success of the SFE3 or 6 months

The SFE surgery is successful if no inflammatory complications occur in the 3- or 6-month-long healing period and the bone volume is sufficient for dental implant placement.

Success of the dental implants5 years

According to The International Congress of Oral Implantologists (ICOI) Pisa Consensus Conference.

Success (optimum health)

1. No pain or tenderness upon function

2. 0 mobility

3. less than 2 mm radiographic bone loss from initial surgery

4. No exudates in the patient's history

II. Satisfactory survival

1. No pain on function

2. 0 mobility

3. 2-4 mm radiographic bone loss

4. No exudates in the patient's history

III. Compromised survival

1. May have sensitivity on function

2. No mobility

3. Radiographic bone loss of more than 4 mm (less than1/2 of the length of the implant body)

4. Probing depth more than 7 mm

5. May have exudates in the patient's history

IV. Failure (clinical or absolute failure)

Any of the following:

1. Pain on function

2. Mobility

3. Radiographic bone loss of more than 1/2 length of the implant

4. Uncontrolled exudate

5. Implant no longer in mouth

Success of the implant borne prostheses5 years

Prostheses with four or fewer complications (screw loosening, decementation, chipping) that could be treated chairside.

Secondary Outcome Measures
NameTimeMethod
Hisomorphometry: Percent of residual bone graft particles3-6 months

The percentage of residual bone graft particle-area measured on the representative sections prepared from the bone core biopsy samples. Unit: percent (%)

Value of the Connectivity (Conn.), calculated from the microCT reconstructions of the bone core biopsy samples.3-6 months

One useful and fast algorithm for calculating the Euler connectivity in 3D is the "Conneulor". It measures what might be called "redundant connectivity", the degree to which parts of the object are multiply connected. It is a measure of how many connections in a structure can be severed before the structure falls into two separate pieces. Unit: none.

Hisomorphometry: Percent of bone marrow3-6 months

The percentage of bone marrow-area measured on the representative sections prepared from the bone core biopsy samples. Unit: percent (%)

Value of the percent bone volume (BV/TV) calculated from the microCT reconstructions of the bone core biopsy samples.3-6 months

Relative volume of calcified tissue in the selected volume. Unit: none

Value of the bone surface to volume ratio (BS/TV), calculated from the microCT reconstructions of the bone core biopsy samples.3-6 months

Ratio of the segmented bone surface to the total volume in the region of interest. Unit: 1/mm

Value of the trabecular thickness (Tb.Th.), calculated from the microCT reconstructions of the bone core biopsy samples.3-6 months

Mean thickness of the trabeculae, assessed using direct 3D methods. Unit: mm

Value of the trabecular separation (Tb.Sp.), calculated from the microCT reconstructions of the bone core biopsy samples.3-6 months

Mean distance between the trabeculae, assessed using direct 3D methods. Unit: mm

Value of the trabecular bone pattern factor (Tb.Pf), calculated from the microCT reconstructions of the bone core biopsy samples.3-6 months

Indicator of the relation between convex and concave elements in the trabecular bone structure. Tb.Pf \<0 when the trabecular bone is honeycomb-like and increases as the trabecular bone acquires a rod-like structure. Unit: none

Value of the structure model index (SMI), calculated from the microCT reconstructions of the bone core biopsy samples.3-6 months

The estimator of the plate- versus rod-like characteristic of the trabecular bone structure, 0 for perfect plates, 3 for perfect rods, and 4 for perfect spheres. Unit: none

Hisomorphometry: Percent of newly formed bone3-6 months

The percentage of newly formed bone-area measured on the representative sections prepared from the bone core biopsy samples. Unit: percent (%)

Value of the Total porosity (Po(tot)), calculated from the microCT reconstructions of the bone core biopsy samples.3-6 months

Percent porosity is the volume of pores as a percent of the total volume of interest (VOI). Unit: percent (%)

Trial Locations

Locations (1)

Semmelweis University Department of Public Dental Health

🇭🇺

Budapest, Hungary

© Copyright 2025. All Rights Reserved by MedPath